Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Reviews in Endocrine and Metabolic Disorders

Issue 1/2010

Special Issue on Cardiovascular Disease and Type 2 Diabetes, Guest Editor: James L. Rosenzweig

Content (9 Articles)

The economic consequences of diabetes and cardiovascular disease in the United States

Miguel A. Ariza, Varsha G. Vimalananda, James L. Rosenzweig

Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus

Neal B. Patel, Gary J. Balady

Impact of cardiovascular outcomes on the development and approval of medications for the treatment of diabetes mellitus

Hylton V. Joffe, Mary H. Parks, Robert Temple

Diabetic cardiomyopathy, causes and effects

Sihem Boudina, Evan Dale Abel

Management of dyslipidemia in people with type 2 diabetes mellitus

Fredrick L. Dunn

Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community

David S. Siscovick, Nona Sotoodehnia, Thomas D. Rea, Trivellore E. Raghunathan, Xavier Jouven, Rozenn N. Lemaitre

Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications

Corey E. Tabit, William B. Chung, Naomi M. Hamburg, Joseph A. Vita

Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting

Doron Aronson, Elazer R. Edelman

Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting

Matteo Anselmino, Klas Malmberg, Linda Mellbin, Lars Rydén

Dec 09
Issue: 4/2009
Special Issue on Circadian Rhythms, Guest Editor: Jimo Borjigin
Jun 10
Issue: 2/2010
Special Issue on Cushing's Syndrome, Guest Editor: David C. Aron

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits